NeOnc Technologies Holdings, Inc. (NTHI)
NASDAQ: NTHI · Real-Time Price · USD
4.910
+0.060 (1.24%)
At close: Nov 13, 2026, 4:00 PM EST
4.940
+0.030 (0.61%)
After-hours: Nov 13, 2026, 7:30 PM EST
NeOnc Technologies Holdings Earnings Call Transcripts
Fiscal Year 2026
-
Stockholders elected two Class I directors and approved the equity-plan expansion and FY2026 auditor appointment. The conditional adjournment proposal was also approved, and a quorum was established.
-
NEO100, delivered intranasally, showed a median overall survival of 26.09 months in recurrent IDH1 mutant high-grade glioma, far exceeding the historical six to nine months. The phase II-A trial met its primary endpoint with a PFS6 of 48.9%, and demonstrated durable disease control and favorable tolerability.